Swedish startups are significantly better in 2026 than before AI

Yesterday, after three consecutive startup meetings, my colleague Anders Hallin blurted out in our office: “The last company I talked with was number three among the startups I met today, but it would have been one of the top five startups I met in 2022.”

Anders’ comment captures something important about the AI startup wave: the quality of Swedish pre-seed and seed-stage startups is at a completely different level in 2026 than in the pre-AI days of 2021 and 2022.

Today’s startups are building better products, solving more complex problems, signing more customers and growing revenue faster than the previous generation.

But being better than the past is not enough when the competition has also gotten better. It is no longer enough to build the proverbial 10x product to raise venture capital. In the fall of 2026, I think a startup needs both a 50x product and a faster go-to-market motion to attract the funding we read about in the headlines.

This is important to keep in mind when discussing startups getting higher valuations today than a few years ago.

Alliance VC invests in Stockholm-based Spiich Labs

I’m happy to have been driving Alliance VC’s investment into Spiich Labs‘ €3 million seed round that was announced today (EU-Startups, TechFundingNews, Breakit, Shifter.no, company announcement)

Salespeople spend just 22% of their time with customers. The rest is spent on tasks such as prospecting, planning and data entry. Spiich’s AI agents take over all of it, so reps can get back to what actually closes deals: time with customers.

Spiich has 50+ customers across 15 countries, grew ARR 100%+ month on month in H1 2026 with 160% net revenue retention, and its customers have closed 50,000+ deals through the platform.

Tandem Health raises $100m (reportedly at $500m valuation)

Stockholm-based Tandem Health has raised $100 million (according to Dagens Industri at a valuation just over 5 billion SEK or $500 million). The round was led by the currently very active Scaleup Europe Fund with Kinnevik, Northzone and other previous investors participating.

Tandem claims that “peer-reviewed research has shown that clinicians using Tandem report a 29% reduction in time spent on admin, 30% improvement in job satisfaction and a 30% reduction in administrative stress¹”. Those are major numbers that, if generally applicable, could improve how the European healthcare systems work for doctors, nurses and other employees.